LOGIN  |  REGISTER
Terns Pharmaceuticals

List of Healthcare Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 333.79
-7.77 -2.27
10.71M
905.84M
US$ 302.360B
US$ 461.56
1.88 0.41
1.16M
228.19M
US$ 105.320B
US$ 78.44
0.29 0.37
7.85M
1.27B
US$ 99.620B
US$ 313.19
-4.01 -1.26
1.39M
222.24M
US$ 69.600B
US$ 258.62
14.21 5.81
5.36M
267.13M
US$ 69.090B
US$ 292.72
1.52 0.52
842,801
163.91M
US$ 47.980B
US$ 74.47
-0.48 -0.64
3.11M
456.56M
US$ 34.000B
US$ 279.92
1.73 0.62
1.22M
120.27M
US$ 33.670B
US$ 201.39
-5.10 -2.47
1.18M
87.88M
US$ 17.700B
US$ 34.50
-0.87 -2.46
8.79M
491.52M
US$ 16.960B
US$ 26.35
-0.49 -1.83
631,943
586.83M
US$ 15.460B
US$ 220.70
3.64 1.68
680,629
56.39M
US$ 12.450B
US$ 68.12
-0.92 -1.33
1.27M
173.39M
US$ 11.810B
US$ 116.07
2.22 1.95
1.32M
100.72M
US$ 11.690B
US$ 180.13
0.03 0.02
347,109
57.70M
US$ 10.390B
US$ 11.98
0.00 0.00
0
865.56M
US$ 10.370B
US$ 66.95
0.93 1.41
1.03M
136.40M
US$ 9.130B
US$ 119.05
0.03 0.03
1.33M
70.60M
US$ 8.400B
US$ 94.81
0.23 0.24
334,586
86.16M
US$ 8.170B
US$ 147.03
-6.03 -3.94
2.15M
51.40M
US$ 7.560B
US$ 37.03
1.18 3.29
2.71M
190.88M
US$ 7.070B
US$ 440.68
9.38 2.17
196,920
14.57M
US$ 6.420B
US$ 14.31
0.00 0.00
0
422.39M
US$ 6.040B
US$ 33.49
0.44 1.33
2.81M
179.80M
US$ 6.020B
US$ 26.42
0.39 1.50
2.82M
162.30M
US$ 4.290B
US$ 17.87
-0.13 -0.72
7.64M
223.04M
US$ 3.990B
US$ 138.30
1.39 1.02
338,083
28.73M
US$ 3.970B
US$ 16.84
-0.02 -0.12
4.83M
198.03M
US$ 3.330B
US$ 100.99
0.00 0.00
0
32.89M
US$ 3.320B
US$ 24.76
0.46 1.89
502,874
122.73M
US$ 3.040B
US$ 21.70
-0.23 -1.05
710,426
128.21M
US$ 2.780B
US$ 28.19
0.07 0.25
823,347
82.68M
US$ 2.330B
US$ 118.99
2.10 1.80
145,555
18.41M
US$ 2.190B
US$ 9.17
-0.10 -1.08
2.29M
237.49M
US$ 2.180B
US$ 14.68
0.11 0.75
425,588
143.11M
US$ 2.100B
US$ 21.31
-0.19 -0.88
929,231
92.35M
US$ 1.970B
US$ 9.41
0.37 4.09
1.07M
208.91M
US$ 1.970B
US$ 4.92
0.02 0.41
1.31M
388.94M
US$ 1.910B
US$ 11.70
0.07 0.60
1.03M
160.62M
US$ 1.880B
US$ 121.04
1.60 1.34
53,659
15.50M
US$ 1.880B
US$ 21.08
4.11 24.22
2.98M
87.08M
US$ 1.840B
US$ 13.42
-0.41 -2.96
1.44M
123.82M
US$ 1.660B
US$ 18.43
-0.28 -1.50
1.09M
85.98M
US$ 1.580B
US$ 13.70
0.06 0.44
2.42M
114.41M
US$ 1.570B
US$ 3.68
0.15 4.25
16.23M
420.14M
US$ 1.550B
US$ 33.37
-0.20 -0.60
390,386
45.93M
US$ 1.530B
US$ 32.99
1.78 5.70
476,264
46.16M
US$ 1.520B
US$ 8.17
-0.46 -5.33
10.40M
177.47M
US$ 1.450B
US$ 22.73
0.09 0.40
394,665
59.91M
US$ 1.360B
US$ 20.55
-0.49 -2.33
724,567
64.44M
US$ 1.320B
US$ 86.93
0.82 0.95
178,783
15.20M
US$ 1.320B
C$ 5.16
-0.09 -1.71
1.26M
253.68M
C$ 1.310B
US$ 17.88
0.01 0.06
629,531
72.41M
US$ 1.290B
US$ 28.27
0.23 0.82
216,442
36.25M
US$ 1.020B
US$ 25.05
0.32 1.29
284,475
34.56M
US$ 865.730M
US$ 6.72
0.05 0.75
4.39M
115.97M
US$ 779.320M
US$ 25.32
0.72 2.93
138,341
29.64M
US$ 750.480M
US$ 19.58
-0.11 -0.56
497,197
38.32M
US$ 750.310M
US$ 131.71
8.65 7.03
57,109
5.56M
US$ 732.310M
C$ 10.87
-0.09 -0.82
78,694
62.83M
C$ 682.960M
US$ 10.39
-0.02 -0.19
890,972
62.44M
US$ 648.750M
US$ 4.74
0.25 5.57
106,830
135.68M
US$ 643.120M
US$ 6.89
0.00 0.00
0
81.68M
US$ 562.780M
US$ 3.28
0.04 1.23
3.31M
167.47M
US$ 549.300M
US$ 3.85
-0.03 -0.77
2.45M
138.52M
US$ 533.300M
US$ 1.43
0.00 0.00
0
371.88M
US$ 531.790M
US$ 4.80
0.00 0.00
37,579
108.90M
US$ 522.720M
US$ 25.62
-0.28 -1.08
21,524
18.82M
US$ 482.170M
US$ 29.20
0.00 0.00
0
16.17M
US$ 472.160M
US$ 8.31
0.18 2.21
434,601
50.69M
US$ 421.230M
US$ 4.49
0.03 0.67
1.79M
93.50M
US$ 419.820M
C$ 1.45
-0.03 -2.03
528,610
265.74M
C$ 385.320M
US$ 19.44
-1.05 -5.12
270,426
18.57M
US$ 361.000M
US$ 0.83
0.03 3.70
11.51M
414.42M
US$ 342.310M
US$ 16.94
-0.24 -1.40
191,439
20.13M
US$ 341.000M
US$ 5.00
0.00 0.00
166,419
67.58M
US$ 337.900M
US$ 3.31
-0.06 -1.78
2.06M
98.58M
US$ 326.300M
US$ 2.86
0.09 3.25
443,329
104.09M
US$ 297.700M
US$ 3.47
0.56 19.24
7.68M
83.72M
US$ 290.510M
US$ 19.20
-0.02 -0.10
40,696
15.01M
US$ 288.190M
US$ 13.91
-0.38 -2.66
215,397
20.59M
US$ 286.410M
C$ 14.44
-0.01 -0.07
24,425
18.86M
C$ 272.340M
US$ 9.15
0.00 0.00
525
29.25M
US$ 267.640M
US$ 3.14
-0.09 -2.79
983,028
70.37M
US$ 220.960M
C$ 3.50
-0.09 -2.51
8,400
62.93M
C$ 220.260M
US$ 5.59
-0.32 -5.41
94,043
30.00M
US$ 167.700M
US$ 24.94
0.00 0.00
0
5.98M
US$ 149.140M
US$ 3.01
0.06 2.03
488,078
42.32M
US$ 127.380M
US$ 7.87
-0.02 -0.25
26,800
15.19M
US$ 119.470M
US$ 2.35
0.00 0.00
0
49.43M
US$ 116.160M
C$ 1.25
0.03 2.46
28,434
85.85M
C$ 107.310M
US$ 3.87
0.00 0.00
0
27.47M
US$ 106.310M
US$ 1.03
-0.06 -5.50
2.62M
97.81M
US$ 100.740M
US$ 2.83
-0.04 -1.39
58,211
31.69M
US$ 89.680M
US$ 2.37
0.27 12.86
129,506
37.77M
US$ 89.510M
US$ 1.77
-0.35 -16.51
1.43M
46.10M
US$ 81.600M
US$ 5.09
-0.13 -2.49
147,804
14.50M
US$ 73.810M
US$ 2.23
-0.01 -0.45
23,539
31.11M
US$ 69.380M
US$ 6.75
0.00 0.00
0
9.02M
US$ 60.880M
US$ 0.70
0.48 218.18
793.68M
73.84M
US$ 51.690M
US$ 4.49
-0.02 -0.44
1,527
8.06M
US$ 36.190M
US$ 2.05
0.00 0.00
0
16.39M
US$ 33.600M
US$ 8.85
0.10 1.14
606
3.27M
US$ 28.950M
C$ 0.29
0.02 5.56
31,365
87.31M
C$ 24.880M
US$ 1.42
-0.03 -2.07
1,009
17.42M
US$ 24.740M
US$ 5.33
0.00 0.00
0
4.36M
US$ 23.240M
US$ 1.86
-0.23 -11.00
744,581
11.44M
US$ 21.280M
C$ 0.38
0.005 1.35
7,000
56.60M
C$ 21.220M
US$ 0.72
0.04 5.43
65,757
24.84M
US$ 17.880M
US$ 0.21
0.00 0.00
0
82.96M
US$ 17.180M
C$ 1.20
0.00 0.00
14,620
14.05M
C$ 16.860M
US$ 2.74
-0.06 -2.14
324,655
5.87M
US$ 16.080M
US$ 5.67
0.21 3.85
3,317
2.82M
US$ 15.990M
US$ 2.10
-0.16 -7.08
38,324
6.51M
US$ 13.670M
US$ 1.16
-0.11 -8.66
636,510
10.40M
US$ 12.060M
C$ 0.13
0.00 0.00
0
93.47M
C$ 11.680M
US$ 1.12
0.00 0.00
0
7.04M
US$ 7.880M
US$ 0.30
0.00 0.00
0
18.91M
US$ 5.710M
C$ 0.03
0.00 0.00
0
176.89M
C$ 5.310M
US$ 2.77
0.00 0.00
0
1.88M
US$ 5.220M
US$ 7.83
0.07 0.90
23,657
582,371
US$ 4.560M
US$ 0.68
0.00 0.00
0
4.41M
US$ 2.980M
US$ 0.28
-0.02 -7.01
3.69M
9.95M
US$ 2.830M
US$ 2.36
-0.24 -9.23
34,819
936,956
US$ 2.210M
C$ 0.03
0.00 0.00
0
55.51M
C$ 1.670M
US$ 0.42
0.00 0.00
0
3.81M
US$ 1.610M
C$ 0.02
0.00 0.00
0
47.62M
C$ 952K
C$ 0.01
0.00 0.00
0
89.59M
C$ 896K
C$ 0.01
0.00 0.00
0
87.10M
C$ 871K
C$ 0.005
0.00 0.00
0
173.26M
C$ 866K
US$ 0.07
0.00 0.00
2,325
11.34M
US$ 760K
US$ 0.06
0.00 0.00
0
7.08M
US$ 426K
US$ 0.05
0.00 0.00
0
3.13M
US$ 150K
US$ 0.005
0.00 0.00
20
19.73M
US$ 99K
US$ 0.00
-0.0001 -100.00
132
-
US$ -
US$ 11.79
-0.29 -2.40
742,938
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -

Latest Healthcare Stock News


Auna Announces Successful Pricing of 8.750% Senior Secured Notes Due 2032

LUXEMBOURG / Nov 04, 2025 / Business Wire / Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal amount of 8.750% Senior Secured Notes due 2032 (the “Notes”) to be issued by the Company and Oncosalud S.A.C. (“Oncosalud” and, together with the Company, the “Co-Issuers”), as co-issuers, which includes (i) U.... Read more


CareRx Reports Results for the Third Quarter of 2025

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the third quarter that ended September 30, 2025. Highlights for the Third Quarter of 2025 Average Beds Serviced1 increased to 91,298 as of September 30, 2025. Revenue increased to $93.2 million... Read more


Tenet Healthcare Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes

DALLAS / Nov 03, 2025 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the “first lien notes”), and $0.75 billion in aggregate principal amount of senior notes due November 15, 2033, which... Read more


HealthStream Announces Third Quarter 2025 Results

NASHVILLE, Tenn. / Nov 03, 2025 / Business Wire / HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, announced today results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenues of $76.5 million in the third quarter of 2025, up 4.6% from $73.1 million in the third quarter of 2024, setting a new Company record for quarterly revenue Operating income of $7.6 million in the third... Read more


Ensign Reports Third Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance

Conference Call and Webcast scheduled for tomorrow, November 4, 2025 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the third quarter of 2025, reporting GAAP... Read more


Addus HomeCare Announces Third Quarter 2025 Financial Results

Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services FRISCO, Texas / Nov 03, 2025 / Business Wire / Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted... Read more


GE HealthCare management to present at upcoming investor conference

CHICAGO / Nov 03, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT A webcast of this event can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-events/events on the date and time listed above. About... Read more


Pediatrix Medical Reports Third Quarter Results

Raises Full Year 2025 Adjusted EBITDA Outlook Range FORT LAUDERDALE, Fla. / Nov 03, 2025 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493 million; Net income of $72 million;... Read more


Ensign Adds Operation in Alabama

SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of The Health Center of Eastview, a 90-bed skilled nursing facility located in Birmingham,... Read more


Ensign Expands in Utah

SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of the following skilled nursing facilities: Stonehenge of American Fork,... Read more


HEALWELL AI Announces Strategic Divestments and Progression to a Pure-Play SaaS, Services and AI Business

HEALWELL has divested its Polyclinic Family Medicine and Specialty Group of Clinics to WELL Health Clinic Network Inc. ("WELL Clinics"), who has been previously managing these clinics for HEALWELL since January 2024. HEALWELL has sold its interest in Mutuo Health Solutions Inc. ("Mutuo") to WELLSTAR Technologies Corp. ("WELLSTAR"), so it can better focus on its large enterprise healthcare software and AI business. Mutuo is primarily focused on selling solutions to doctors... Read more


Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service

WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025. During her over eight years of dedicated service, Ms. Clinton played a pivotal role in guiding Clover’s evolution from a privately held... Read more


HCA Healthcare to Present at November Healthcare Conferences

NASHVILLE, Tenn. / Oct 31, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: November 12, 2025 at 9:30am ET at the 2025 UBS Global Healthcare Conference November 17, 2025 at 12:00pm ET at the 2025 Wolfe Research Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s... Read more


WELL Subsidiary WELLSTAR Technologies Announces $62M Financing to Support Its Pre-Spinout Growth Strategy

WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives. The financing is anticipated to close early December, subject to certain closing conditions. WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers... Read more


Select Medical Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend

MECHANICSBURG, Pa., Oct. 30, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended September 30, 2025, and the declaration of a cash dividend. For the third quarter ended September 30, 2025, revenue increased 7.2% to $1,363.4 million, compared to $1,271.6 million for the same quarter, prior year. Income from continuing operations before other income and expense... Read more


Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapies RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution. QSP has rapidly become a cornerstone of modern drug discovery and development... Read more


Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics

Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Has 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare,... Read more


Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

Fresenius Medical Care researchers will present multiple abstracts that demonstrate proven, real-world benefits of hemodiafiltration (HDF), with one accepted as an oral presentation. Oral presentation highlights the association between HDF and reduced risk of cardiovascular and fluid-related hospitalization outcomes. Research shows how artificial intelligence is moving from theory into practice, supporting clinicians and patients in daily kidney disease care. BAD... Read more


Talkspace Announces Third Quarter 2025 Results

3Q 2025 Total revenue grew 25% year-over-year to $59.4 million driven by 42% year-over-year growth in Payor revenue 3Q 2025 Net income of $3.3 million and adjusted EBITDA¹ of $5.0 million 3Q 2025 Share repurchases of $8.8 million NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK), today reported third quarter 2025 financial results.     Three Months EndedSeptember 30, &... Read more


Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (Year-over-year comparisons unless otherwise noted) Net revenue of $1,435.0 million, up 12.2% Gross profit of... Read more


Omnicell Announces Third Quarter 2025 Financial Results

Omnicell delivers strong third quarter financial results Results exceed previously issued third quarter 2025 guidance on all metrics Raises full year 2025 total revenues, non-GAAP EBITDA and non-GAAP EPS guidance FORT WORTH, Texas / Oct 30, 2025 / Business Wire / Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced... Read more


Cigna Reports Strong Third Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook

Total revenues for the third quarter 2025 increased 10% to $69.7 billion Shareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per share Adjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 The Cigna Group announced a new rebate-free pharmacy benefit model designed to lower costs, improve transparency, and... Read more


HEALWELL AI's Orion Health Signs Memorandum of Understanding with Lean Business Services to Advance AI-Powered Healthcare in Saudi Arabia & Across the Middle East

HEALWELL AI and its subsidiary Orion Health have signed a Memorandum of Understanding (MoU) with Lean Business Services, to jointly explore the development and commercialization of digital health and AI-driven solutions across the Middle East and Orion's global markets. The MoU leverages complementary strengths across technology, innovation, and market access, focusing on AI driven population health, clinical AI, and data-interoperability. Initial areas of collaboration... Read more


Encompass Health reports results for third quarter 2025

Increases full-year guidance BIRMINGHAM, Ala., Oct. 29, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2025. Summary results           Growth   Q3 2025   Q3 2024   Dollars   Percent... Read more


Universal Health Services To Present At The 2025 Wolfe Research Healthcare Conference

KING OF PRUSSIA, Pa., Oct. 29, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the Wolfe Research Healthcare Conference 2025 in New York, New York on Wednesday, November 19, 2025, at 8:00 a.m. EST. A live audio webcast of the presentation and a webcast replay will be available at the Investor Relations section of  the Company's website (www.uhsinc.com). Universal Health Services, Inc. is one of the nation's largest hospital... Read more


DaVita Announces 3rd Quarter 2025 Results

DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. "Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance," said Javier Rodriguez, CEO of DaVita. "Our consistent focus on providing outstanding care is the key to these results, enabling us to continuously invest in improving the lives of our patients and supporting... Read more


Waystar Reports Third Quarter 2025 Results

Q3 revenue growth of 12% year-over-year Q3 net income of $30.6 million and non-GAAP net income of $67.8 million Q3 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., Oct. 29, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the third quarter ended September 30, 2025. "Waystar delivered... Read more


Spok Reports Third Quarter 2025 Results

Continued Managed Services Revenue Growth and Focused Expense Management Drives Net Income Levels Company Reaffirms 2025 Financial Guidance PLANO, Texas / Oct 29, 2025 / Business Wire / Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the third quarter ended September 30, 2025. In addition, the Company’s Board of Directors declared a regular quarterly dividend of $0.3125 per share, payable on December 9,... Read more


Teladoc Health Reports Third Quarter 2025 Results

NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter 2024”). Highlights Third Quarter 2025 revenue of $626.4 million, down 2% year-over-year Third Quarter 2025 net loss... Read more


10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based multiplexing. The new assay delivers cost-effective, highly scalable single... Read more


CVS Health Reports Third Quarter 2025 Results And Updates Full-Year 2025 Guidance

Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior year Third quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit Third quarter Adjusted EPS of $1.60 Generated year-to-date cash flow from operations of $7.2 billion Operational Highlights Aetna® receives industry-leading Medicare Advantage Star... Read more


NetraMark Presents AI-Driven Advances in Precision Psychiatry to Enhance Clinical Trial Designs at Joint Autumn Conference

TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, presented two significant applications of its technology at the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn conference and the European College... Read more


GE HealthCare reports third quarter 2025 financial results

Revenue growth was 6% and Organic revenue growth* was 4% year-over year, driven by Europe, the Middle East and Africa (EMEA) and the U.S. Organic orders growth was 6% with growth across all segments Net income margin was 8.7%; Adjusted earnings before interest and taxes (EBIT) margin* was 14.8% Diluted earnings per share (EPS) were $0.98; Adjusted EPS* was $1.07 Cash flow from operating activities was $593 million; Free cash flow* was $483 million Excluding tariff... Read more


Centene Reports Third Quarter 2025 Results

GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%. $6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to... Read more


Chemed Reports Third-Quarter 2025 Results

CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated... Read more


LifeStance Health to Present at the UBS Global Healthcare Conference

SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL. Details of the presentation are as follows:Presenter: Dave Bourdon, CEODate: Monday, November 10, 2025 Time: 4:15 p.m. (Eastern time)Moderated by: Kevin Caliendo The... Read more


BrightSpring Health Services Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

LOUISVILLE, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2025, increased Revenue guidance, and reiterated Adjusted EBITDA1 guidance. Financial Highlights (note: all figures represent continuing operations and exclude the... Read more


Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care

Collaboration Will Simplify and Streamline Users' Ability to Find Personalized Care Delivered by Licensed Mental Health Clinicians PALO ALTO, Calif. and SCOTTSDALE, Ariz., Oct. 28, 2025 /PRNewswire/ -- Calm Health, Calm's evidence-based mental health app available through health plans, providers and employers, today announced it has partnered with LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care. Through... Read more


Tenet Healthcare Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook

Net income available to common shareholders in third quarter 2025 was $342 million, or $3.86 per diluted share Adjusted diluted earnings per share1 increased 26.3% to $3.70 in third quarter 2025 compared to $2.93 in third quarter 2024 Consolidated Adjusted EBITDA1 in third quarter 2025 increased 12.4% to $1.099 billion compared to third quarter 2024; Third quarter 2025 Adjusted EBITDA margin was 20.8% Third quarter 2025 Ambulatory Care Adjusted EBITDA of $492 million... Read more


GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Reported third quarter 2025 revenues of $116.7 million with 65% year-over-year growth in exome and genome test revenue Accelerated exome and genome volume growth to 33% year-over-year Expanded adjusted gross margin to 74% and generated adjusted net income1 of $14.7 million for the third quarter 2025 Raised guidance to deliver between $425 and $428 million in revenue with between 53% to 55% full year growth in exome and genome revenue Granted FDA Breakthrough Device... Read more


UnitedHealth Reports Third Quarter 2025 Results and Raises Full Year 2025 Earnings Outlook

Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, Adjusted Earnings $2.92 Per Share Cash Flows from Operations were $5.9 Billion, or 2.3x Net Income Raises Full Year 2025 Earnings Outlook to at least $14.90 Per Share; Adjusted Earnings of at least $16.25 Per Share - / Oct 28, 2025 / Business Wire / UnitedHealth Group (NYSE: UNH) reported third quarter 2025 results, reflecting the continued execution on... Read more


Universal Health Services Announces Financial Results For The Three And Nine-Month Periods Ended September 30, 2025, Increases 2025 Full Year Operating Results Forecast And Announces $1.5 Billion Increase...

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended September 30, 2025 and 2024 KING OF PRUSSIA, Pa., Oct. 27, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $373.0 million, or $5.86 per diluted share, during the third quarter of 2025, as compared to $258.7 million, or $3.80 per diluted share, during the third quarter of 2024. Net revenues... Read more


Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for P...

Powered by DataVault AI's High-Performance Computing & Information Exchange, Data Monetization for Traditional and Compound Pharmacies is Set to Become a Reality in the $639 Billion Prescription Drug Market, with Beta Testing Expected in First Half of 2026 Tampa, Florida and Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2025) - Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics"), a leader in next-generation pharmaceutical distribution,... Read more


HCA Healthcare Announces Proposed Public Offering of Senior Notes

NASHVILLE, Tenn. / Oct 27, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include... Read more


HCA Healthcare Reports Third Quarter 2025 Results

Raises 2025 Guidance NASHVILLE, Tenn. / Oct 24, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share... Read more


Community Health Systems Announces Third Quarter Ended September 30, 2025 Results

FRANKLIN, Tenn. / Oct 23, 2025 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and nine months ended September 30, 2025. The following highlights the financial and operating results for the three months ended September 30, 2025. Net operating revenues totaled $3.087 billion. Net income attributable to Community Health Systems, Inc. stockholders was $130 million, or $0.96 per... Read more


EUDA Health Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India

SINGAPORE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, CK Health Plus Sdn. Bhd. (“CK Health Plus”), will expand into the Indian market through a strategic master license and representative partnership with SafeRock India Private Limited (“SafeRock... Read more


Molina Healthcare Reports Third Quarter 2025 Financial Results

Revises Full Year 2025 Guidance LONG BEACH, Calif. / Oct 22, 2025 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below:   Three months ended   Nine months ended   September 30,   September 30,   202... Read more


GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Data from more than 22,000 newborns reinforce GeneDx’s role spearheading the adoption of genomic newborn screening (gNBS) from research to clinical practice GAITHERSBURG, Md. / Oct 22, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced data and presentations at the International Consortium on Newborn Sequencing (ICoNS), underscoring the company’s leadership in driving genomic newborn... Read more


Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

Provides preliminary fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10 Fourth quarter and fiscal year 2025 results to be reported December 1, 2025 RESEARCH TRIANGLE PARK, N.C. / Oct 22, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical... Read more